PMN: Rubino Ivana discloses securities transactions
By AlphaYouPublished Form 4
Rubino Ivana
Reporting filer
Rubino Ivana reported Grant or award in ProMIS Neurosciences Inc.: 80000 units of Option (right to buy) (derivative), dated 2026-10-05. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy) (derivative) | Rubino Ivana | 2026-10-05 | A | Grant or award | 80000 | 0 | 80,000 | 1 day | Filed terms
|
Option (right to buy) (derivative)
- Owner
- Rubino Ivana
- Date
- 2026-10-05
- Code
- A
- Action
- Grant or award
- Quantity
- 80000
- Price
- 0
- Following holdings
- 80,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Option (right to buy)
- conversion Or Exercise Price: 9.37
- transaction Date: 2026-10-05
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 80000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-05
- underlying Security Title: Common Shares
- underlying Security Shares: 80000
- shares Owned Following Transaction: 80000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Rubino Ivana: Chief Commercial Officer.
- F1: 25% of the shares subject to this option shall vest on October 5, 2026, with the remaining shares vesting monthly over the three (3) years thereafter, subject to continued service to the Issuer through each vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.